findmyKOL

Anna Hemnes, MD

Enriched profile

Chair, Department of Medicine and System Physician-in-Chief, Vanderbilt Health; Professor of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine (holder of the Elsa S. Hanigan Chair in Pulmonary Medicine) · Vanderbilt University Medical Center

ORCIDNPI
Region🇺🇸 Nashville, TN · Southeast · United StatesSpecialtyPulmonary DiseaseFocusPulmonary Hypertension Research and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2006–2026

Anna Hemnes is Chair, Department of Medicine and System Physician-in-Chief, Vanderbilt Health; Professor of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine (holder of the Elsa S. Hanigan Chair in Pulmonary Medicine) at Vanderbilt University Medical Center. OpenAlex indexes 470 publications with 12,964 citations (h-index 60); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Anna Hemnes, MD, is Chair, Department of Medicine and System Physician-in-Chief, Vanderbilt Health at Vanderbilt University Medical Center. The public record shows 470 publications with 12,964 citations (h-index 60), centered on Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies, 11 NIH-funded awards (2006–2026).

  • Most recent indexed publication: 2026 · Circulation research
  • Top research focus: Pulmonary Hypertension Research and Treatments
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypertension4 trialsPulmonary Hypertension3 trialsPulmonary Arterial Hypertension3 trialsLung Diseases2 trialsFamilial Primary Pulmonary Hypertension2 trialsMalnutrition1 trialHeart FailureCOPDIdiopathic Pulmonary Fibrosis

Research focus

OpenAlex concept fingerprint
Pulmonary Hypertension Research and TreatmentsCardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementChronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Drugs & molecules

across trials, industry payments and publications
Winrevairgeneric · SotaterceptClinical trialsIndustry payments45Publications1Remodulingeneric · TreprostinilClinical trialsIndustry payments27PublicationsOpsumitgeneric · MacitentanClinical trialsIndustry payments4Publications

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trialsIndustry payments73United Therapeutics CorporationClinical trialsIndustry payments50Actelion Pharmaceuticals, LtdClinical trialsIndustry payments8

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
470publications

Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.

12,964citations

Total citations across indexed works.

60h-index

Hirsch index (OpenAlex). i10-index 178.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
11NIH grants · 2006–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    48.9%
    Endothelin Receptor Antagonist30.1%
    Ambrisentan70%Opsumit19%Letairis12%
    Part D<11 patients
    Loop diuretic8.7%
    Furosemide73%Torsemide27%
    Part D<11 patients
  • Genitourinary & hormones

    43.7%
    Phosphodiesterase 5 Inhibitor43.7%
    Tadalafil57%Sildenafil Citrate39%Adcirca4%
    Part D<11 patients
  • Blood & clotting

    4.1%
    Prostacyclin Receptor Agonist2.5%
    Uptravi100%
    Part D<11 patients
    Vitamin K antagonist1.6%
    Warfarin Sodium100%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B), 2023100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

11 NIH research awards on record, funded 20062026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/anna-hemnes-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/scientific-contributions/Anna-R-Hemnes-38756330

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/anna-hemnes-419a08114

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/VUMCDiscoveries/status/1775196208211931556

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • LinkedIn

    LinkedIn: Anna Hemnes, MD at Vanderbilt University (personal profile, auth-walled)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Critical Care Medicine, American Board of Internal Medicine

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com
  • Board Certified

    Pulmonary Disease, American Board of Internal Medicine

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com
  • M.D.

    Johns Hopkins University School of Medicine

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com
  • B.A.

    Biology and Anthropology, Columbia University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org

Editorial & leadership roles

journal and society appointments
  • Board Director and President

    Pulmonary Vascular Research Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wag.app.vanderbilt.edu
  • Immediate past chair

    Pulmonary Hypertension Association Scientific Leadership Council

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org
  • Co-Editor-in-Chief

    Pulmonary Circulation (journal)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org
  • Physician-in-Chief

    Vanderbilt Lung Institute; Director, Center for Lung Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.vumc.org

Media & interviews

press, podcasts and appearances
  • "Beyond the Dome: Anna Hemnes"

    Johns Hopkins Medicine profile feature

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org
  • Panelist

    CHEST podcast on Pulmonary Arterial Hypertension Treatment Guidelines (moderated by D. Kyle Hogarth, MD)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journal.chestnet.org
  • Panelist

    "PH Roundtable: The ABCs of Pulmonary Hypertension," Advances in Pulmonary Hypertension (with John Ryan, MD and Brad Maron, MD)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →meridian.allenpress.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.